Further investigation of WIP, its interactions with various binding partners, and the processes regulating its activity may provide a deeper understanding of the regulation and function of immune cells, and may pave the way for the development of novel therapies for primary immunodeficiencies, infectious diseases, and other pathological conditions. Here, WIPF1 is linked to inborn error of immunity.